GKOS · GLAUKOS Corp · Webcasts, Transcripts & Audio
$245.72
-0.31 (-0.13%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$14.55B
Shares
59.20M
Volume · Nov 13
546.55K
Avg daily vol (3M)
1.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
GLAUKOS Corp Webcasts
Earnings calls, investor updates, investor days and conferences for GLAUKOS Corp (GKOS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-02
GLAUKOS Corp (GKOS) December 2, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-12-01
GLAUKOS Corp (GKOS) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-18
GLAUKOS Corp (GKOS) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
GLAUKOS Corp (GKOS) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-28
GLAUKOS Corp (GKOS) Q3 2026 Earnings Call Transcript
Confident tone
Epioxa commercial launch
Medicare coverage uncertainty
Keratoconus awareness and screening
Revenue
$211.03M
▲ 58% YoY Diluted EPS
$0.03
Gross margin
85.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-09
GLAUKOS Corp (GKOS) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-29
GLAUKOS Corp (GKOS) Q2 2026 Earnings Call Transcript
Confident tone
Epioxa (corneal cross-linking) launch
iDose TR (U.S. Glaucoma) growth
iDose re-administration and cannibalization
Revenue
$185.61M
▲ 49.5% YoY Diluted EPS
$-0.31
Gross margin
81.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-16
GLAUKOS Corp (GKOS) June 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
GLAUKOS Corp (GKOS) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
GLAUKOS Corp (GKOS) June 2, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-29
GLAUKOS Corp (GKOS) Q1 2026 Earnings Call Transcript
Confident tone
Epioxa launch and corneal cross-linking
iDose TR commercial momentum
Reimbursement, access, and payer dynamics
Revenue
$150.57M
▲ 41.2% YoY Diluted EPS
$-0.34
Gross margin
77.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
GLAUKOS Corp (GKOS) Q4 2025 Earnings Call Transcript
Confident tone
Photrexa transition to Epioxa
Pipeline and R&D investment
2026 guidance and outlook
Revenue
$143.12M*
▲ 35.7% YoY Gross margin
-1.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
GLAUKOS Corp (GKOS) Q3 2025 Earnings Call Transcript
Confident tone
Epioxa FDA approval and launch
Interventional Glaucoma / standalone MIGS opportunity
iDose TR launch momentum
Revenue
$133.54M
▲ 38.1% YoY Diluted EPS
$-0.28
Gross margin
78.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
GLAUKOS Corp (GKOS) Q2 2025 Earnings Call Transcript
Confident tone
International Growth & EU Approvals
Capital Allocation / Cash Flow
MIGS / Stent Market Headwinds (MAC LCDs)
Revenue
$124.12M
▲ 29.7% YoY Diluted EPS
$-0.34
Gross margin
78.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
GLAUKOS Corp (GKOS) Q1 2025 Earnings Call Transcript
Confident tone
Interventional glaucoma (IG) category development
iDose TR launch and adoption
Corneal health and Epioxa pipeline
Revenue
$106.66M
▲ 24.6% YoY Diluted EPS
$-0.32
Gross margin
77.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
GLAUKOS Corp (GKOS) Q4 2024 Earnings Call
Confident tone
2025 Financial Guidance
Reimbursement and Market Access
iDose TR Commercial Launch
Revenue
$105.50M*
▲ 28.1% YoY Gross margin
72.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
GLAUKOS Corp (GKOS) Q3 2024 Earnings Call Transcript
Confident tone
Reimbursement and J-code Progress
MIGS LCD Coverage and Medicare Advantage
iDose TR Commercial Launch
Revenue
$96.67M
▲ 23.9% YoY Diluted EPS
$-0.39
Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
GLAUKOS Corp (GKOS) Q2 2024 Earnings Call Transcript
Positive tone
iDose TR Launch
Operating Expenses / Financial Outlook
U.S. Interventional Glaucoma Franchise / iStent
Revenue
$95.69M
▲ 19% YoY Diluted EPS
$-1.00
Gross margin
76.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
GLAUKOS Corp (GKOS) Q1 2024 Earnings Call Transcript
Confident tone
U.S. glaucoma franchise growth
iDose TR launch and commercial rollout
iDose TR reimbursement and market access
Revenue
$85.62M
▲ 15.9% YoY Diluted EPS
$-0.82
Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
GLAUKOS Corp (GKOS) Q4 2023 Earnings Call Transcript
Confident tone
U.S. Glaucoma Franchise / iStent infinite
iDose TR Launch
Pipeline / R&D
Revenue
$82.36M*
▲ 15.6% YoY Gross margin
77.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
GLAUKOS Corp (GKOS) Q3 2023 Earnings Call Transcript
Revenue
$78.05M
▲ 9.5% YoY Diluted EPS
$-0.63
Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
GLAUKOS Corp (GKOS) Q2 2023 Earnings Call Transcript
Revenue
$80.40M
▲ 10.6% YoY Diluted EPS
$-0.68
Gross margin
75.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
GLAUKOS Corp (GKOS) Q1 2023 Earnings Call Transcript
Revenue
$73.90M
▲ 9.2% YoY Diluted EPS
$-0.72
▼ 754.5% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
GLAUKOS Corp (GKOS) Q4 2022 Earnings Call Transcript
Revenue
$71.23M
▼ 2.7% YoY Diluted EPS
$-0.66
▼ 240.4% YoY Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
GLAUKOS Corp (GKOS) Q3 2022 Earnings Call Transcript
Revenue
$71.27M
▼ 4.6% YoY Diluted EPS
$-0.58
▼ 546.2% YoY Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
GLAUKOS Corp (GKOS) Q2 2022 Earnings Call Transcript
Revenue
$72.69M
▼ 6.9% YoY Diluted EPS
$-0.96
Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-23
GLAUKOS Corp (GKOS) Q1 2022 Earnings Call Transcript
Revenue
$67.68M
▼ 0.4% YoY Diluted EPS
$0.11
Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
GLAUKOS Corp (GKOS) Q4 2021 Earnings Call Transcript
Revenue
$73.24M
▲ 0% YoY Diluted EPS
$0.47
Gross margin
77.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
GLAUKOS Corp (GKOS) Q3 2021 Earnings Call Transcript
Revenue
$74.71M
▲ 15.2% YoY Diluted EPS
$0.13
Gross margin
79.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
GLAUKOS Corp (GKOS) Q2 2021 Earnings Call Transcript
Revenue
$78.09M
▲ 147.5% YoY Diluted EPS
$-0.38
Gross margin
77.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
GLAUKOS Corp (GKOS) Q1 2021 Earnings Call Transcript
Revenue
$67.97M
▲ 22.8% YoY Diluted EPS
$-0.36
Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
GLAUKOS Corp (GKOS) Q4 2020 Earnings Call Transcript
Revenue
$73.23M
▲ 11.2% YoY Diluted EPS
$-0.24
▼ 128.6% YoY Gross margin
73.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
GLAUKOS Corp (GKOS) Q3 2020 Earnings Call Transcript
Revenue
$64.83M
▲ 10.8% YoY Diluted EPS
$-0.35
Gross margin
72.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
GLAUKOS Corp (GKOS) Q2 2020 Earnings Call Transcript
Revenue
$31.56M
▼ 46.1% YoY Diluted EPS
$-0.90
Gross margin
31.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
GLAUKOS Corp (GKOS) Q1 2020 Earnings Call Transcript
Revenue
$55.34M
▲ 2.4% YoY Diluted EPS
$-1.24
Gross margin
41.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-28
GLAUKOS Corp (GKOS) Q4 2019 Earnings Call
Revenue
$65.85M
▲ 21.8% YoY Diluted EPS
$0.84
▲ 2000% YoY Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–36 of 36 webcasts
Key facts
CIK
1192448
CUSIP
377322102
13F (30d)
331 filings
301 filers
Visit website
Investor relations